Dr Ruby Lin

Associate Professor
Centre for Infectious Diseases and Microbiology

Telephone 0286273414

Website LinkedIn
ResearchGate
Australasian Genomic Technologies Association

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Schelch, K., Wagner, C., Hager, S., Pirker, C., Siess, K., Lang, E., Lin, R., Kirschner, M., Mohr, T., Brcic, L., Reid, G., van Zandwijk, N., et al (2018). FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal. Carcinogenesis, 39(4), 534-545. [More Information]
  • Duncan, T., Lowe, A., Sidhu, K., Sachdev, P., Lewis, T., Lin, R., Sytnyk, V., Valenzuela, M. (2017). Replicable Expansion and Differentiation of Neural Precursors from Adult Canine Skin. Stem cell reports, 9(2), 557-570. [More Information]
  • Ooi, J., Bernardo, B., Singla, S., Patterson, N., Lin, R., McMullen, J. (2016). Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases. RNA Biology, 14(5), 500-513. [More Information]
  • Bernardo, B., Nguyen, S., Gao, X., Tham, Y., Ooi, J., Patterson, N., Kiriazis, H., Su, Y., Thomas, C., Lin, R., et al (2016). Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload. Scientific Reports, 6, 22442. [More Information]
  • Bernardo, B., Ooi, J., Matsumoto, A., Tham, Y., Singla, S., Kiriazis, H., Patterson, N., Sadoshima, J., Obad, S., Lin, R., et al (2016). Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: Identification of sex-, disease- and treatment-regulated miRNAs. Journal of Physiology, 594(20), 5959-5974. [More Information]
  • Bernardo, B., Ooi, J., Lin, R., McMullen, J. (2015). miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Medicinal Chemistry, 7(13), 1771-1792. [More Information]
  • Liu, L., Jiang, Q., Wang, X., Zhang, Y., Lin, R., Lam, S., Shui, G., Zhou, L., Li, P., Wang, Y., et al (2014). Adipose-specific knockout of seipin/bscl2 results in progressive lipodystrophy. Diabetes, 63(7), 2320-2331. [More Information]
  • Lin, R., Ng, S., Morris, M. (2014). Gene expression in rat models for inter-generational transmission of islet dysfunction and obesity. Genomics Data, 2, 351-353. [More Information]
  • Bernardo, B., Gao, X., Tham, Y., Kiriazis, H., Winbanks, C., Ooi, J., Boey, E., Obad, S., Kauppinen, S., Gregorevic, P., et al (2014). Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PloS One, 9(2), 1-13. [More Information]
  • Bernardo, B., Nguyen, S., Winbanks, C., Gao, X., Boey, E., Tham, Y., Kiriazis, H., Ooi, J., Porrello, E., Lin, R., et al (2014). Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. The FASEB Journal, 28(12), 597-5110. [More Information]
  • Bernardo, B., Charchar, F., Lin, R., McMullen, J. (2012). A microRNA guide for clinicians and basic scientists: background and experimental techniques. Heart, Lung and Circulation, 21(3), 131-142. [More Information]
  • Cooley, N., Cowley, M., Lin, R., Marasco, S., Wong, C., Kaye, D., Dart, A., Woodcock, E. (2012). Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiological Genomics, 44(3), 211-219. [More Information]
  • Bernardo, B., Gao, X., Winbanks, C., Boey, E., Tham, Y., Kiriazis, H., Gregorevic, P., Obad, S., Kauppinen, S., Du, X., et al (2012). Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proceedings of the National Academy of Sciences of the United States of America, 109(43), 17615-17620. [More Information]
  • Fei, W., Shui, G., Zhang, Y., Krahmer, N., Ferguson, C., Kapterian, T., Lin, R., Dawes, I., Brown, A., Li, P., et al (2011). A role for phosphatidic Acid in the formation of supersized" lipid droplets". PLoS Genetics, 7(7), e1002201. [More Information]
  • Huang, K., Lin, R., Kormas, N., Lee, L., Chen, C., Gill, T., Caterson, I. (2004). Plasma Leptin Is Associated With Insulin Resistance Independent Of Age, Body Mass Index, Fat Mass, Lipids, And Pubertal Development In Nondiabetic Adolescents. International Journal of Obesity, 28(4), 470-475. [More Information]
  • Lin, R., Wang, X., Morris, B. (2003). Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension, 41(3), 404-407. [More Information]
  • Lin, R., Dalziel, B., Caterson, I., Wang, X., Morris, B. (2003). Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S Variant. Obesity Research, 11(6), 802-808.
  • Morris, B., Benjafield, A., Lin, R. (2003). Essential hypertension: genes and dreams. Clinical Chemistry and Laboratory Medicine, 41(7), 834-844. [More Information]
  • Kumar, N., Benjafield, A., Lin, R., Wang, W., Stowasser, M., Morris, B. (2003). Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. Journal of Hypertension, 21(7), 1331-1337. [More Information]
  • Morris, B., Lin, R., Wang, X. (2003). Response. Hypertension, 11. [More Information]
  • Morris, B., Lin, R., Dalziel, B., Caterson, I., Wang, X. (2003). Response: Central obesity is associated with glucocorticoid receptor N363S variant: Big picture sheds light. Obesity Research, 11, 1607-1609.
  • Morris, B., Lin, R., Wang, X., Dalziel, B., Caterson, I. (2003). Response: Central obesity is associated with Glucocorticoid Receptor N363S Variant: Big Picture Sheds Light. Obesity Research, 11(12), 1607-1609.
  • Lin, R., Schyvens, C., Zhang, Y., Whitworth, J., Morris, B. (2003). Tumor necrosis factor receptor 2 mRNA in rat models of hypertension. American Journal of Hypertension, 16(8), 685-688. [More Information]
  • Lin, R., Morris, B. (2002). Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. American Journal of Medical Genetics, Part A, 107(4), 311-316.
  • Hui, J., Farrell, G., Lin, R., Samarasinghe, D., Liddle, C., George, J., Kench, J., Byth, K. (2002). Hepatic Steatosis in Chronic Hepatitis C Infection. Journal of Gastroenterology and Hepatology, 17(8), 873-881.
  • Lin, R., Benjafield, A., Morris, B., Ericsson, J. (2001). Association of beta 2-adrenoceptor Gln27Glu variant with body weight but not hypertension. American Journal of Hypertension, 14, 1201-1204.
  • Benjafield, A., Lin, R., Dalziel, B., Gosby, A., Caterson, I., Morris, B. (2001). G-protein B3 subunit gene splice variant in obesity and overweight. International Journal of Obesity, 25, 777-780.

2018

  • Schelch, K., Wagner, C., Hager, S., Pirker, C., Siess, K., Lang, E., Lin, R., Kirschner, M., Mohr, T., Brcic, L., Reid, G., van Zandwijk, N., et al (2018). FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal. Carcinogenesis, 39(4), 534-545. [More Information]

2017

  • Duncan, T., Lowe, A., Sidhu, K., Sachdev, P., Lewis, T., Lin, R., Sytnyk, V., Valenzuela, M. (2017). Replicable Expansion and Differentiation of Neural Precursors from Adult Canine Skin. Stem cell reports, 9(2), 557-570. [More Information]

2016

  • Ooi, J., Bernardo, B., Singla, S., Patterson, N., Lin, R., McMullen, J. (2016). Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases. RNA Biology, 14(5), 500-513. [More Information]
  • Bernardo, B., Nguyen, S., Gao, X., Tham, Y., Ooi, J., Patterson, N., Kiriazis, H., Su, Y., Thomas, C., Lin, R., et al (2016). Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload. Scientific Reports, 6, 22442. [More Information]
  • Bernardo, B., Ooi, J., Matsumoto, A., Tham, Y., Singla, S., Kiriazis, H., Patterson, N., Sadoshima, J., Obad, S., Lin, R., et al (2016). Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: Identification of sex-, disease- and treatment-regulated miRNAs. Journal of Physiology, 594(20), 5959-5974. [More Information]

2015

  • Bernardo, B., Ooi, J., Lin, R., McMullen, J. (2015). miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Medicinal Chemistry, 7(13), 1771-1792. [More Information]

2014

  • Liu, L., Jiang, Q., Wang, X., Zhang, Y., Lin, R., Lam, S., Shui, G., Zhou, L., Li, P., Wang, Y., et al (2014). Adipose-specific knockout of seipin/bscl2 results in progressive lipodystrophy. Diabetes, 63(7), 2320-2331. [More Information]
  • Lin, R., Ng, S., Morris, M. (2014). Gene expression in rat models for inter-generational transmission of islet dysfunction and obesity. Genomics Data, 2, 351-353. [More Information]
  • Bernardo, B., Gao, X., Tham, Y., Kiriazis, H., Winbanks, C., Ooi, J., Boey, E., Obad, S., Kauppinen, S., Gregorevic, P., et al (2014). Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PloS One, 9(2), 1-13. [More Information]
  • Bernardo, B., Nguyen, S., Winbanks, C., Gao, X., Boey, E., Tham, Y., Kiriazis, H., Ooi, J., Porrello, E., Lin, R., et al (2014). Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. The FASEB Journal, 28(12), 597-5110. [More Information]

2012

  • Bernardo, B., Charchar, F., Lin, R., McMullen, J. (2012). A microRNA guide for clinicians and basic scientists: background and experimental techniques. Heart, Lung and Circulation, 21(3), 131-142. [More Information]
  • Cooley, N., Cowley, M., Lin, R., Marasco, S., Wong, C., Kaye, D., Dart, A., Woodcock, E. (2012). Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiological Genomics, 44(3), 211-219. [More Information]
  • Bernardo, B., Gao, X., Winbanks, C., Boey, E., Tham, Y., Kiriazis, H., Gregorevic, P., Obad, S., Kauppinen, S., Du, X., et al (2012). Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proceedings of the National Academy of Sciences of the United States of America, 109(43), 17615-17620. [More Information]

2011

  • Fei, W., Shui, G., Zhang, Y., Krahmer, N., Ferguson, C., Kapterian, T., Lin, R., Dawes, I., Brown, A., Li, P., et al (2011). A role for phosphatidic Acid in the formation of supersized" lipid droplets". PLoS Genetics, 7(7), e1002201. [More Information]

2004

  • Huang, K., Lin, R., Kormas, N., Lee, L., Chen, C., Gill, T., Caterson, I. (2004). Plasma Leptin Is Associated With Insulin Resistance Independent Of Age, Body Mass Index, Fat Mass, Lipids, And Pubertal Development In Nondiabetic Adolescents. International Journal of Obesity, 28(4), 470-475. [More Information]

2003

  • Lin, R., Wang, X., Morris, B. (2003). Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension, 41(3), 404-407. [More Information]
  • Lin, R., Dalziel, B., Caterson, I., Wang, X., Morris, B. (2003). Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S Variant. Obesity Research, 11(6), 802-808.
  • Morris, B., Benjafield, A., Lin, R. (2003). Essential hypertension: genes and dreams. Clinical Chemistry and Laboratory Medicine, 41(7), 834-844. [More Information]
  • Kumar, N., Benjafield, A., Lin, R., Wang, W., Stowasser, M., Morris, B. (2003). Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. Journal of Hypertension, 21(7), 1331-1337. [More Information]
  • Morris, B., Lin, R., Wang, X. (2003). Response. Hypertension, 11. [More Information]
  • Morris, B., Lin, R., Dalziel, B., Caterson, I., Wang, X. (2003). Response: Central obesity is associated with glucocorticoid receptor N363S variant: Big picture sheds light. Obesity Research, 11, 1607-1609.
  • Morris, B., Lin, R., Wang, X., Dalziel, B., Caterson, I. (2003). Response: Central obesity is associated with Glucocorticoid Receptor N363S Variant: Big Picture Sheds Light. Obesity Research, 11(12), 1607-1609.
  • Lin, R., Schyvens, C., Zhang, Y., Whitworth, J., Morris, B. (2003). Tumor necrosis factor receptor 2 mRNA in rat models of hypertension. American Journal of Hypertension, 16(8), 685-688. [More Information]

2002

  • Lin, R., Morris, B. (2002). Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. American Journal of Medical Genetics, Part A, 107(4), 311-316.
  • Hui, J., Farrell, G., Lin, R., Samarasinghe, D., Liddle, C., George, J., Kench, J., Byth, K. (2002). Hepatic Steatosis in Chronic Hepatitis C Infection. Journal of Gastroenterology and Hepatology, 17(8), 873-881.

2001

  • Lin, R., Benjafield, A., Morris, B., Ericsson, J. (2001). Association of beta 2-adrenoceptor Gln27Glu variant with body weight but not hypertension. American Journal of Hypertension, 14, 1201-1204.
  • Benjafield, A., Lin, R., Dalziel, B., Gosby, A., Caterson, I., Morris, B. (2001). G-protein B3 subunit gene splice variant in obesity and overweight. International Journal of Obesity, 25, 777-780.

To update your profile click here. For support on your academic profile contact .